| Literature DB >> 32160224 |
Luis Pezo-Lanfranco1, José Filippini1, Marina Di Giusto2, Cecília Petronilho1, Veronica Wesolowski2, Paulo DeBlasis2, Sabine Eggers1,3.
Abstract
In this study, we shed light on the interdependency of child growth, morbidity and life expectancy in the fisher-hunter-gatherers of the Jabuticabeira II shell mound (1214-830 cal B.C.E. - 118-413 cal C.E.) located at the South Coast of Brazil. We test the underlying causes of heterogeneity in frailty and selective mortality in a population that inhabits a plentiful environment in sedentary settlements. We reconstruct osteobiographies of 41 individuals (23 adults and 18 subadults) using 8 variables, including age-at-death, stature, non-specific stress markers (cribra orbitalia, porotic hyperostosis, periosteal reactions, periapical lesions and linear enamel hypoplasia), as well as weaning patterns based on stable isotope data to examine how stress factors module growth and survival. Our results show that shorter adult statures were linked to higher morbidity around weaning age and higher chances of dying earlier (before 35 years) than taller adult statures. In addition, short juvenile stature was related to physiological stressors and mortality. The adult "survivors" experienced recurrent periods of morbidity during childhood and adulthood, possibly associated with the high parasite load of the ecosystem and dense settlement rather than to malnourishment. An association between early-stress exposure and premature death was not demonstrated in our sample. To explain our data, we propose a new model called "intermittent stress of low lethality". According to this model, individuals are exposed to recurrent stress during the juvenile and adult stages of life, and, nevertheless survive until reproductive age or later with relative success.Entities:
Year: 2020 PMID: 32160224 PMCID: PMC7065757 DOI: 10.1371/journal.pone.0229684
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Setting of Jabuticabeira II.
The star represents Jabuticabeira II, the triangles represent other sambaquis mapped for the Laguna Region (modified from Boyadjian et al. [31:137]).
Fig 2Femoral lengths by age in juveniles from Jabuticabeira II and reference populations.
Asterisks represent the individual values of Jabuticabeira II juveniles. For the compared populations marks represent mean values and the lines represent the range of variability. DGS: Denver Growth Study.
Operationalization of stress markers in dichotomous variables for logistic regression analysis.
| Dichotomous variable | Infant malnutrition | Infant morbidity | Juvenile short height-by-age (stunting) | Adult relative short height | Adult morbidity | Early mortality | |||
|---|---|---|---|---|---|---|---|---|---|
| Juveniles | Adults | Juveniles | Adults | Juveniles | Adults | Adults | Juveniles | Adults | |
| No (0) | Breastfed: δ15N > 2‰ above the female mean value and/or Mean weaning-age: 2–3 years old | No stress markers | No LEH | Long bone length into/above the range of variability and/or HAZ > -2 SD | Stature above the group median (in M, F) or Z-score > 0 | No stress markers | >1 year old (1–20 years) | Late death: Adult older than 35 years | |
| Yes (1) | Non-breastfed: δ15N around or below the female mean value and/or Early weaning-age: < 2 years old | Presence of CO, PH, PR, PL, LEH and/or number of markers ≥ 1 | Presence of LEH and/or > LEH Incidence period (years with LEH) | Long bone length below the range of variability and/or HAZ ≤-2 SD | Stature below the group median (M, F) or Z-score < 0 | Presence of CO, PH, PR, PL and/or number of markers ≥ 1 | ≤ 1year old | Early death: Young Adult (20–35 years) | |
1 Lack of breastfeeding or early weaning.
2Subadults (non-survivors, individuals who die early in childhood)
3Adults (survivors, individuals who survive to later life-stages). CO: cribra orbitalia; PH: porotic hyperostosis; PR: periosteal reactions and other signs of bone infection; PL: periapical lesions; LEH: linear enamel hypoplasia; HAZ (height-for-age Z-score).
Osteobiographic aspects in adults from Jabuticabeira II (n = 23).
| N° | Individual | Sex | Age at death | Bone | Length (mm) | Estimated stature (cm) | Z score (according sex) | Age at the end of weaning | # LEH (age-range) | LEH incidence | CO | PH | PR | # PL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SEP 34 L2.05 | F | YA | femur | 361 | 141.08 ±1.844 | -2.738 | < 3 yr | 2 (4.0–4.8) | 0.8 | CO | PH | PR | 0 |
| tibia | 302 | |||||||||||||
| 2 | SEP 36A L2.05 | M | YA | tibia | 327 | 150.12 ± 2.581 | -1.246 | ~2 yr | 6 (2.6–4.9) | 2.3 | CO | PH | PR | 4 |
| 3 | SEP 37 L2.05 | M | OA | radius | 236 | 158.05 ± 3.467 | 0.434 | 2–3 yr | 6 (2.5–4.8) | 2.3 | CO | PH | 5 | |
| 4 | SEP 40 L2.05 | F | Adult | humerus | 259 | 142.94 ± 2.975 | -2.396 | ~2 yr? | 7 (2.2–5.6) | 3.4 | CO | PH | PR | 2 |
| 5 | SEP 41A L2.05 | M | Adult | femur | 386 | 150.49 ± 2.627 | -1.167 | < 3 yr | 2 (4.0–4.8) | 0.8 | PH | PR | 3 | |
| 6 | SEP 108 L2.05 | F | MA | ulna | 239 | 151.44 ± 3.987 | 0.837 | 2–3 yr | no hypoplasia | 8 | ||||
| 7 | SEP 110 prof L2 | M | YA | femur | 425 | 159.32 ± 2.289 | 0.703 | < 4 yr | 6 (1.5–5.1) | 3.6 | 0 | |||
| tibia | 352 | |||||||||||||
| 8 | SEP 11 L1.25 | M | MA | femur | 403 | 153.27 ± 2.289 | -0.578 | 2–3 yr | 3 (2.4–5.6) | 3.2 | PH | 2 | ||
| tibia | 334 | |||||||||||||
| 9 | SEP 12B L1.25 | M | YA | humerus | 295 | 154.30 ± 2.975 | -0.360 | 2–3 yr | no hypoplasia | 0 | ||||
| 10 | SEP 24 L1-1.20 | M | Adult | ulna | 237 | 151.10 ± 3.615 | -1.038 | 2–3 yr | nr | nr | ||||
| 11 | SEP 14 L1.05 | F | YA | tibia | 338 | 151.35 ± 1.963 | 0.853 | ~2 yr | 2 (4.0–4.3) | 0.3 | 0 | |||
| 12 | SEP 15A L1.05 | M | MA | radius | 257 | 166.83 ± 3.467 | 2.294 | < 3 yr | 2 (2.1–4.9) | 2.8 | PR | 11 | ||
| 13 | SEP 17 A L1.05 | M | MA | femur | 430 | 161.17 ± 2.289 | 1.095 | < 4 yr | no hypoplasia | PH | PR | 0 | ||
| tibia | 359 | |||||||||||||
| 14 | SEP 41 L1 | M | Adult | humerus | 290 | 154.78 ± 3.522 | -0.259 | 2–3 yr | nr | nr | ||||
| 15 | SEP 102 L1.75 | F | Adult | humerus | 284 | 150.83 ± 2.975 | -0.949 | 2–3 yr | no hypoplasia | CO | PH | PR | 0 | |
| 16 | SEP 123 L1.80 | M | MA | humerus | 299 | 157.91 ± 3.522 | 0.405 | 2–3 yr | nr | nr | nr | PR | nr | |
| 17 | SEP 107 L1-T1 | M | OA | humerus | 297 | 157.22 ± 3.522 | 0.256 | 2–3 yr | no hypoplasia | CO | PH | 3 | ||
| 18 | SEP 2A L6 | F | MA | radius | 209 | 147.02 ± 3.012 | -0.648 | 2–3 yr | no hypoplasia | CO | PH | 0 | ||
| 19 | SEP 114 L6 | M | OA | radius | 246 | 162.23 ± 3.467 | 1.320 | 2–3 yr | 2 (4.4–4.8) | 0.8 | nr | PH | nr | |
| 20 | SEP 115B L6 | M | MA | femur | 398 | 151.09 ± 2.289 | -1.040 | ~2 yr | 2 (4.0–4.8) | 0.8 | PH | 0 | ||
| tibia | 325 | |||||||||||||
| 21 | SEP 118 L6 | M | YA | femur | 402 | 153.62 ± 2.289 | -0.504 | 2–3 yr | 7 (2.9–5.6) | 2.7 | CO | PH | PR | 0 |
| tibia | 337 | |||||||||||||
| 22 | SEP 121 L6 | M | MA | humerus | 298 | 157.56 ± 3.522 | 0.331 | 2–3 yr | 2 (3.7–4.9) | 1.2 | CO | PH | PR | 8 |
| 23 | SEP 333A L6 | F | YA | radius | 233 | 156.79 ± 3.467 | 0.145 | 2–3 yr | nr | nr | nr | PR | nr |
* Individuals whose final weaning age was not possible to be estimated, were considered as having been weaned at age 2–3 years. CO: cribra orbitalia; PH: porotic hyperostosis; PR: periosteal reactions and bone infections; #PL: number of periapical lesions of maxilla and mandible. NR: not recordable.
†Maximum period between the first and last hypoplasias calculated in years according to Reid and Dean [67].
Dental age, long bone lengths and estimated stature in juveniles from Jabuticabeira II (n = 18).
| N° | Individual | Dental age | Bone | Length (mm) | Range of long bones lengths (mm) | Estimated stature (cm) | % of adult femur length attained | Compatible with stunting? | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ubelaker 1999 | Gaither 2004 | EUA 20th century | Arikara | Andean | Ruff 2007 | Z-score | ||||||
| 1 | SEP 35A - L2.05 | 6±3 m | 6±2 m | femur | 77 | 79.4–118.2 | 62.5–106.0 | 77.4–131.0 | 55.93 ± 1.7 | M = -6.07 | 0.19 (0.23) | Yes |
| F = -4.89 | ||||||||||||
| 2 | SEP 17D1—L1.05 | 6±3 m | 6±2 m | humerus | 65 | 79.9–91.6 | 63.5–89.0 | 67.0–81.6 | ? | - | - | Yes |
| SEP 17B- L1.05 | 6±3 m | 6±2 m | humerus | 82 | 79.9–91.6 | 63.5–89.0 | 67.0–81.6 | ? | M = -2.03 | - | No | |
| tibia | 83 | 81.6–98.1 | 59.5–94.0 | 65.6–103.0 | 64.70 ± 1.5 | F = -1.10 | ||||||
| 4 | SEP 41B - L2.05 | 9±3 m | 6±2 m | humerus | 72 | - | 84.0–119.0 | 70.2–88.9 | ? | M = -5.56 | 0.21 (0.26) | Yes |
| femur | 83 | - | 92.5–161.0 | 92.0–110.2 | 57.75 ± 1.7 | F = -6.79 | ||||||
| 5 | SEP 3F - L6 | 9±3 m | 6±2 m | humerus | 75 | - | 84.0–119.0 | 70.2–88.9 | ? | M = -5.66 | 0.23 (0.26) | Yes |
| femur | 91 | - | 92.5–161.0 | 92.0–110.2 | 60.33 ± 1.6 | F = -4.51 | ||||||
| tibia | 76 | - | 81.0–131.5 | 77.4–93.0 | ||||||||
| 6 | SEP 115A-L6 | 9±3 m | 6±2 m | humerus | 86 | - | 84.0–119.0 | 70.2–88.9 | ? | M = 0.11 | 0.27 (0.26) | No |
| femur | 108 | - | 92.5–161.0 | 92.0–110.2 | 73.52 ± 1.5 | F = 0.83 | ||||||
| 7 | SEP 17D2—L1.05 | 9±3 m | 6±2 m | radius | 69 | - | 84.0–104.0 | 55.0–72.2 | 69.33 ± 2.0 | M = -1.72 | - | No |
| F = -0.87 | ||||||||||||
| 8 | SEP 120—L2.05 | 12±4 m | 9±2 m | humerus | 100 | 97.3–112.1 | 84.0–119.0 | 83.8–98.7 | ? | - | - | No |
| 9 | FS30—L1.70 | 12±4 m | 9±2 m | femur | 100 | 128.0–143.0 | 92.5–161.0 | 104.5–140.9 | 62.90 ± 1.7 | M = -5.40 | 0.25 (0.28) | Yes |
| F = -4.31 | ||||||||||||
| 10 | SEP 17D - L1.05 | 12±4 m | 9±2 m | femur | 105 | 128.0–143.0 | 92.5–161.0 | 104.5–140.9 | 64.42 ± 1.7 | M = -4.76 | 0.26 (0.28) | Yes |
| F = -3.72 | ||||||||||||
| 11 | SEP BEBÊ - L1/L2 | 12±4 m | 9±2 m | humerus | 96 | 97.3–112.1 | 84.0–119.0 | 83.8–98.7 | ? | M = -2.98 | 0.29 (0.28) | No |
| femur | 116 | 128.0–143.0 | 92.5–161.0 | 104.5–140.9 | 68.55 ± 1.6 | F = -2.08 | ||||||
| tibia | 98 | 102.6–117.4 | 81.0–131.5 | 85.6–101.5 | ||||||||
| 12 | SEP 35B - L2.05 | 4yr ±12 m | 3yr±11m | femur | 150 | 209.7–238.4 | 208.0–218.0 | 131.0–180.0 | 81.71 ± 1.8 | M = -5.32 | 0.37 (0.46) | Yes |
| tibia | 120 | 168.5–194.4 | 165.0–176.0 | 109.0–139.0 | F = -5.04 | |||||||
| 13 | SEP 101- L2.05 | 4yr ±12 m | 3yr±11m | humerus | 121 | 151.0–171.2 | 154.0–159.0 | 107.0–136.5 | 86.95 ± 2.0 | M = -5.05 | 0.38 (0.46) | Yes |
| femur | 153 | 209.7–238.4 | 208.0–218.0 | 131.0–180.0 | 82.84 ± 2.2 | F = -4.78 | ||||||
| 14 | SEP 119A-L6 | 4yr ±12 m | 3yr±11m | humerus | 139 | 151.0–171.2 | 154.0–159.0 | 107.0–136.5 | 94.27 ± 2.0 | M = -2.25 | 0.47 (0.46) | No |
| femur | 189 | 209.7–238.4 | 208.0–218.0 | 131.0–180.0 | 94.59 ± 1.8 | F = -2.05 | ||||||
| tibia | 160 | 168.5–194.4 | 165.0–176.0 | 109.0–139.0 | ||||||||
| 15 | SEP 16B - L1.05 | 4yr ±12 m | 3yr±11m | humerus | 133 | 151.0–171.2 | 154.0–159.0 | 107.0–136.5 | 91.83 ± 2.0 | M = -3.53 | 0.44(0.46) | Yes |
| femur | 175 | 209.7–238.4 | 208.0–218.0 | 131.0–180.0 | 89.21 ± 1.8 | F = -3.30 | ||||||
| tibia | 141 | 168.5–194.4 | 165.0–176.0 | 109.0–139.0 | ||||||||
| 16 | SEP 38—L2.05 | 7yr ±24 m | 6yr±20m | humerus | 160 | 190.0–215.5 | 187.5–204.0 | 161.0–163.9 | 104.4 ± 2.8 | M = -3.59 | 0.55 (0.59) | Yes |
| femur | 220 | 273.0–308.2 | 252.0–274.0 | 183.8–222.0 | ||||||||
| 103.08 ± 1.9 | F = -3.31 | |||||||||||
| tibia | 178 | 215.8–253.8 | 212.0–229.5 | 178.0–186.0 | ||||||||
| 17 | SEP 10A- L1.25 | 7yr ±24 m | 6yr±20m | humerus | 190 | 190.0–215.5 | 187.5–204.0 | 161.0–163.9 | 117.75 ± 2.8 | M = -1.10 | 0.65 (0.59) | No |
| femur | 261 | 273.0–308.2 | 252.0–274.0 | 183.8–222.0 | 115.87 ± 1.9 | F = -0.90 | ||||||
| tibia | 216 | 215.8–253.8 | 212.0–229.5 | 178.0–186.0 | ||||||||
| 18 | SEP 104A - L1.85 | 15yr±36m | 12yr±21m | humerus | 250 | - | - | 237.0–257.0 | 144.10 ± 3.8 | M = -3.67 | 0.89 (0.97) | Yes |
| femur | 355 | - | 345.0–368.0 | 329.0–338.0 | ||||||||
| tibia | 297 | - | 294.0–319.0 | 264 | 140.24 ± 2.9 | F = -3.11 | ||||||
* The dental aging method by Ubelaker [90] was used to classify Arikara [90] and Andean [100] individuals. Dental aging of Gaither [91] figures in this study as reference due to the possibility of precocious dental eruption in our samples.
1Maresh [98] included bone lengths between 10th and 90th percentiles (in this case the mean value from males and females). The tables by Maresh do not include an age category for around 9 months, nor data of individuals older than 12 years. In this research, the Maresh’s age cohort of 6m includes individuals between 0–6 months.
2Ubelaker [98] includes the complete variability range for each bone
3Vega [100] includes the complete variability range for each bone. The Ubelaker’s phase NB-0.5 yrs equals the phases Nac±2m and 6m±3m by Vega [100]; the phase 0.5–1.5 yr equals the phases 9m±3m and 12m±4m. The tables by Vega [100] are applicable without sexing.
** % femur length attained [103] = individual femur length / average femur length of adults (pooled sample). In brackets the expected value calculated from Denver Growth Study data [98].
Correlations between variables in adults from Jabuticabeira II (females and males pooled).
| Z-scores of adult heights (by sex) vs. | n | Spearman's ρ | Sig. (2-tailed) |
|---|---|---|---|
| First LEH | 13 | -.350 | .240 |
| LEH incidence period | 13 | .223 | .464 |
| # LEH | 19 | -.052 | .833 |
| # stress markers in adulthood | 23 | -.259 | .232 |
| In females | 7 | -.764 | |
| Age-at-death in adulthood | 23 | .409 | .053 |
| First LEH (adults) vs. | |||
| LEH incidence period | 13 | -.946 | |
| in males | 10 | -.938 | |
| in males | 10 | -.979 | |
| # LEH | 13 | -.635 | |
| # stress markers in adulthood | 13 | -.093 | .763 |
| Age-at-death in adulthood | 13 | -.003 | .992 |
| LEH incidence period (adults) vs. | |||
| # LEH | 13 | .765 | |
| # stress markers in adulthood | 13 | .180 | .557 |
| Age-at-death in adulthood | 13 | -.069 | .824 |
| # LEH (adults) | |||
| # stress markers in adulthood | 19 | .367 | .122 |
| Age-at-death in adulthood | 19 | -.231 | .341 |
| Age-at-death in adulthood vs. | |||
| # Periapical lesions | 23 | .493 | |
| Maximum number of stress markers vs. | |||
| Age-at-death in adulthood | 23 | .152 | .489 |
| Age-at-death in childhood | 18 | .384 | .115 |
| Weaning age vs. | |||
| # stress markers in adulthood | 23 | -.203 | .304 |
| # stress markers in childhood | 18 | -.617 | .140 |
| Age-at-death in adulthood | 23 | .145 | .508 |
| Age-at-death in childhood | 18 | .529 | .222 |
#: number of. # stress markers in adulthood = maximum number of stress markers present per individual (the sum of CO, HO, LEH, PR and PL).
Fig 3Height-for-age in individuals from Jabuticabeira II in the WHO developmental charts.
a) Male individuals aged 0–5 years; b) Female individuals aged 0–5 years; c) Male individuals aged 5–19 years; d) Female individuals aged 5–19 years. Points show height-for-age when age-at-death was estimated according to Ubelaker [90] dental chart. Arrows show height-for-age when age-at-death was estimated using the Gaither [91] chart. Red line: 2σ; Blue line: 3σ.
Fig 4Physiological stress markers per individual in adults from Jabuticabeira II.
Fig 5Physiological stress markers by individual in juveniles from Jabuticabeira II.
Osteobiographic aspects in juveniles from Jabuticabeira II (n = 18).
| N° | Individual | Dental age | Compatible with Stunting? | Subadult diet | Age at the end of weaning | # LEH (age range) | LEH incidence | CO | PH | PR | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ubelaker 1999 | Gaither 2004 | ||||||||||
| 1 | SEP 35A - L2.05 | 6±3 m | 6±2 m | Yes | breastfeeding, supplementary? | not weaned | nr | CO | |||
| 2 | SEP 17D1—L1.05 | 6±3 m | 6±2 m | Yes | breastfeeding, supplementary? | nd | nr | nr | |||
| 3 | SEP 17B- L1.05 | 6±3 m | 6±2 m | No | breastfeeding, supplementary? | not weaned | nr | nr | |||
| 4 | SEP 41B - L2.05 | 9±3 m | 6±2 m | Yes | breastfeeding, supplementary? | weaned? | nr | CO | |||
| 5 | SEP 3F - L6 | 9±3 m | 6±2 m | Yes | breastfeeding, supplementary? | not weaned | nr | nr | |||
| 6 | SEP 115A-L6 | 9±3 m | 6±2 m | No | breastfeeding, supplementary? | not weaned | nr | CO | PH | PR | |
| 7 | SEP 17D2—L1.05 | 9±3 m | 6±2 m | No | breastfeeding, supplementary? | not weaned | nr | nr | |||
| 8 | SEP 120—L2.05 | 12±4 m | 9±2 m | No | breastfeeding, supplementary? | not weaned | nr | CO | PR | ||
| 9 | SEP FS30—L1.70 | 12±4 m | 9±2 m | Yes | breastfeeding, supplementary? | nd | nr | nr | |||
| 10 | SEP 17D - L1.05 | 12±4 m | 9±2 m | Yes | breastfeeding, supplementary? | not weaned | nr | nr | |||
| 11 | SEP BEBÊ - L1/L2 | 12±4 m | 9±2 m | No | breastfeeding, supplementary? | not weaned | nr | CO | |||
| 12 | SEP 35B - L2.05 | 4yr±12 m | 3yr±11m | Yes | marine | ~3yr | 2 (2.2–3.7) | 1.5 | CO | PR | |
| 13 | SEP 101- L2.05 | 4yr±12 m | 3yr±11m | Yes | terrestrial | ~3yr | 3 (2.8–4.0) | 2.1 | CO | PH | |
| 14 | SEP 119A-L6 | 4yr±12 m | 3yr±11m | No | mixed | ~3yr | nr | ||||
| 15 | SEP 16B - L1.05 | 4yr±12 m | 3yr±11m | Yes | mixed | < 3yr | no hypoplasia | CO | PH | ||
| 16 | SEP 38—L2.05 | 7yr±24 m | 6yr±20m | Yes | mixed | > 3yr? | 2 (3.7–5.6) | 0.5 | CO | ||
| 17 | SEP 10A- L1.25 | 7yr±24 m | 6yr±20m | No | mixed | > 3yr? | no hypoplasia | ||||
| 18 | SEP 104A - L1.85 | 15yr±36m | 12yr±21m | Yes | mixed | < 3yr | 6 (2.8–5.6) | CO | PH | ||
*ND: individuals without isotopic data for weaning. NR: not recordable or teeth not-erupted. Mixed diet means a different diet from the marine diet typical for Jabuticabeira II adults. CO: cribra orbitalia; PH: porotic hyperostosis; PR: periosteal reactions and bone infections.
†Maximum number of years between the first and last hypoplasia events according to Reid and Dean 2006 [67].